[CAS NO. 933054-33-2]  Monomethyl lithospermate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [933054-33-2]

Catalog
HY-N8931
Brand
MCE
CAS
933054-33-2

DESCRIPTION [933054-33-2]

Overview

MDL-
Molecular Weight552.48
Molecular FormulaC28H24O12
SMILESO=C(/C=C/C1=C2C(O[C@@H]([C@H]2C(OC)=O)C3=CC(O)=C(O)C=C3)=C(O)C=C1)O[C@H](CC4=CC(O)=C(O)C=C4)C(O)=O

For research use only. We do not sell to patients.

Summary

Monomethyl lithospermate activates the PI3K/AKT pathway, which plays a protective role in nerve injury. Monomethyl lithospermate can improve the survival ability of SHSY-5Y cells, inhibit the breakdown of mitochondrial membrane potential (MMOP) and inhibit cell apoptosis . Monomethyl lithospermate also reduced the level of oxidative stress in the brain tissue of rats with middle artery occlusion (MCAO) and improved nerve damage in rats with ischemic stroke (IS) [1] .


In Vitro

Monomethyl lithospermate (5, 10, and 20 μM; 12 h) increases cell viability of SHSY-5Y cells treated by oxygen and glucose deprivation/Reoxygenation (OGD/R) [1] .
Monomethyl lithospermate (20 μM; 12 h) alleviates cell damage, mitochondrial membrane potential loss and apoptosis of SHSY-5Y cells after oxygen and glucose deprivation/reoxygenation [1] .
Monomethyl lithospermate (5, 10, and 20 μM; 12 h) reduces ROS and intracellular oxidative stress in SHSY-5Y cells [1] .
Monomethyl lithospermate (20 μM; 12 h) activates PI3K/AKT in SHSY-5Y cells [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Immunofluorescence [1]

Cell Line: SHSY-5Y cells
Concentration: 5, 10, and 20 μM
Incubation Time: 12 hours
Result: Inhibited the mitochondrial membrane potential (MMOP) collapse and apoptosis of SHSY-5Y cells induced by oxygen and glucose deprivation/Reoxygenation (OGD/R) treatment.

In Vivo

Monomethyl lithospermate (72.4 μM/kg; p.o.; once daily for 14 d) improves the neurological function of middle artery occlusion (MCAO) rats 24 h after ischemia reperfusion (IR), and reduces the size of cerebral infarction; also reduces the level of oxidative stress and inhibit neuronal apoptosis in MCAO rats [1] .
Monomethyl lithospermate can reduce the oxidative stress level and inhibit neuronal apoptosis in MCAO rats [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.



Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.